Abstract
India is the second-largest population in the world, and developing nation, it is not well equipped as compared to other developed countries like China, USA, Italy, Germany. Hitherto, in the scenario of the global pandemic, SARS-CoV-2 affected a hundred thousand people in 202 countries and territories, which could impart a devastating impact on the Indian population. In the absence of vaccines, the only way to respond against this critical condition is by practicing large-scale social distancing. Interestingly, China diminishes COVID-19 cases by forcefully applying strict restrictions to isolate even mild symptomatic individuals; local authorities went door to door for testing, increases the hospital facilities, including ventilators. Likewise, India also took a very bold decision to lock down the whole country for 21 days, starting from 24 March 2020 after detecting 571 positive COVID-19 confirmed cases. However, till 1 April 2020, SARS-CoV-2 positive cases were growing exponentially, which raises the concerns if the number of reported and actual cases are similar. Our analysis suggests that there is an urgent need to take action to extend the period of lockdown and allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. Otherwise, the outbreak in India can reach the level of the USA or Italy or could be worse than these countries within a few days or weeks, given the size of the population and lack of resources.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is found within the manuscript or publicly available through the cited web sources
